APD334
APD334-011
Phase 2 small_molecule terminated
Quick answer
APD334 for Pyoderma Gangrenosum is a Phase 2 program (small_molecule) at Arena Pharmaceutical Enterprises Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arena Pharmaceutical Enterprises Limited
- Indication
- Pyoderma Gangrenosum
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated